tailieunhanh - Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients

Anti-Androgen Receptor (AR) therapy holds promise for a subset of AR expressing triple-negative breast cancer (TNBC) patients. However, current AR assays are suboptimal in detecting the dynamic range of AR expression, contributing to its controversial role in TNBC disease prognosis. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN